You are here

Pfizer

GSK, Novartis, J&J and Pfizer lead pharma at making their meds accessible: report

Fierce Pharma

Tue, 01/26/21 - 11:30 pm

Why Pfizer Will Make More Money Than Originally Expected in 2021

Motley Fool

Tue, 01/26/21 - 11:08 am

COVID-19 Vaccine Leaders Turn Attention to Kids, But Results Not Expected Until 2022

BioSpace

Mon, 01/25/21 - 11:58 pm

clinical trials

Moderna Therapeutics

Pfizer's 6-dose-per-vial OK boosts its supply numbers. The catch? Special syringes are required

Fierce Pharma

Mon, 01/25/21 - 11:53 pm

Pfizer/BioNTech COVID-19 vaccine is safe for elderly people, says WHO

Biopharma Reporter

Fri, 01/22/21 - 10:46 am

Pfizer's R&D president Dolsten: Not taking government cash made us more nimble for COVID-19 vaccine

Fierce Biotech

Fri, 01/22/21 - 10:36 am

Pfizer and BioNTech to Supply WHO's COVID-19 Vaccine Program

Motley Fool

Thu, 01/21/21 - 11:59 pm

Remember normal? Pfizer and BioNTech join with health groups to remind us—and promote COVID-19 vaccine safety

Fierce Pharma

Thu, 01/21/21 - 10:49 am

Pfizer-BioNTech Covid-19 vaccine works just as well against variant first detected in U.K., study indicates

Stat

Wed, 01/20/21 - 10:56 am

B.1.1.7 variant

New York, Michigan governors want to buy COVID-19 vaccines directly from Pfizer

Beckers Hospital Review

Wed, 01/20/21 - 10:41 am

Pfizer and BioNTech, scaling up for 2B coronavirus vaccine doses, temporarily cut deliveries in EU, Canada

Fierce Pharma

Tue, 01/19/21 - 10:55 am

drug manufacturing

Where Will Pfizer Be in 5 Years?

Motley Fool

Tue, 01/19/21 - 10:45 am

Pfizer CEO Backs Biden's Plan for 100 Million Doses in 100 Days

BioSpace

Tue, 01/19/21 - 10:24 am

10 key clinical trials to watch in the first half of 2021

BioPharma Dive

Sun, 01/17/21 - 05:01 pm

clinical trials

SAGE Therapeutics

Vertex Pharmaceuticals

The biotech resurrection continues

EP Vantage

Fri, 01/15/21 - 10:39 am

Lexicon Pharmaceuticals

DBV Technologies

Trillium Therapeutics

Pfizer’s XALKORI approved by FDA for ALK-positive anaplastic large cell lymphoma in children and young adults

Pharmaceutical Business Review

Fri, 01/15/21 - 10:04 am

ALK-positive anaplastic large cell lymphoma

JPM: How did Pfizer up its COVID-19 vaccine capacity? 'Out of the box manufacturing,' CEO says

Fierce Pharma

Wed, 01/13/21 - 11:41 pm

drug manufacturing

A longtime Pfizer chief's ultra-quiet biotech re-emerges with new cash and plans for the clinic

Endpoints

Wed, 01/13/21 - 10:49 am

Elucida Oncology

Merck snags priority review for Prevnar 13 rival — just one month after Pfizer sent its follow-on to the FDA

Endpoints

Tue, 01/12/21 - 10:59 am

pneumococcal disease

priority review

Pfizer invests $120M in 4 biotechs through new growth fund

Fierce Biotech

Tue, 01/12/21 - 10:56 am

Homology Medicines

Vedanta Biosciences

Trillium Therapeutics

Pages